PLAY PODCASTS
Cellular therapy: Responding to COVID-19
Episode 27

Cellular therapy: Responding to COVID-19

In this episode, Allan Dietz, Ph.D., associate professor of Laboratory Medicine and Pathology, instructor in Biochemistry and Molecular Biology, and consultant in the Division of Transfusion Medicine at Mayo Clinic discusses how the field of cellular ther

Lab Medicine Rounds · Mayo Clinic Laboratories

January 22, 202116m 32s

Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Timestamps:

00:00 Intro

00:58 How is cellular therapy contributing to the COVID effort?

04:42 Can you give us a little bit of an introduction about what’s so important about the cell (mesenchymal stem cell) or where it comes from?

08:19 What sort of work are you and your lab doing for patient care?

11:14 Once you figure out a successful cellular therapy, is there then opportunity for that to get brought to scale for a given patient population, or does cellular therapy need to exist as a very individualized treatment?

13:48 For our listeners who might be students or other clinicians or laboratory medicine folks, how can they get involved in cellular therapy or how do you recommend those first steps to learn more about this field and how they might intersect with it?

15:50 Outro

Resources:

https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.20-0472 

https://www.medrxiv.org/content/10.1101/2020.10.15.20122523v2 

Topics

COVID-19cellular therapylaboratory medicine and pathologyMayo Clinic Laboratories